Theralase Technologies Inc
XTSX:TLT
Theralase Technologies Inc
Cash from Financing Activities
Theralase Technologies Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Theralase Technologies Inc
XTSX:TLT
|
Cash from Financing Activities
CA$2.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
4%
|
CAGR 10-Years
0%
|
|
Neovasc Inc
TSX:NVCN
|
Cash from Financing Activities
-$762.3k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Profound Medical Corp
TSX:PRN
|
Cash from Financing Activities
$1.5m
|
CAGR 3-Years
-74%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
|
Opsens Inc
TSX:OPS
|
Cash from Financing Activities
CA$10.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
18%
|
|
Nanalysis Scientific Corp
XTSX:NSCI
|
Cash from Financing Activities
CA$13.2m
|
CAGR 3-Years
17%
|
CAGR 5-Years
128%
|
CAGR 10-Years
N/A
|
|
MedMira Inc
XTSX:MIR
|
Cash from Financing Activities
CA$2.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
29%
|
CAGR 10-Years
-7%
|
See Also
What is Theralase Technologies Inc's Cash from Financing Activities?
Cash from Financing Activities
2.6m
CAD
Based on the financial report for Dec 31, 2023, Theralase Technologies Inc's Cash from Financing Activities amounts to 2.6m CAD.
What is Theralase Technologies Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
0%
Over the last year, the Cash from Financing Activities growth was -12%.